Anisha Devas is a junior at Wharton, concentrating in Health Care Management and minoring in biology. She is fascinated by the intersection of medicine and business and hopes to help reform the inequities in the American healthcare system during her career. Previous research experience includes work in organic chemistry (at Penn’s Vagelos Laboratories), specifically using a variety of techniques, such as titrations and spectroscopy, to identify the ways strong hydrogen bonding molecules could improve drug efficacy. This past summer she worked at  Dr. Yael Mossé's clinical oncology research lab at the Children's Hospital of Pennsylvania. She helped grow different cell lines with Anaplastic Lymphoma Kinase (ALK) mutations (activating mutations in high risk Neuroblastoma cancer) and used Immunoblotting (Western Blot) techniques to asses phosphorylation changes caused by ALK mutations in order to help elucidate full-length ALK receptor signaling in Neuroblastoma and create more precise/mechanistically driven therapies that help prevent/delay resistance.